2027 ICD-10-CM Diagnosis Code G71.20Congenital myopathy, unspecified

ICD-10-CM Codes›G00–G99›G70-G73›G71

ICD-10-CM G71.20
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

G71.20 is a billable ICD-10-CM diagnosis code for congenital myopathy, unspecified. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 91 through 93. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 22 closely related codes. Coders also document this condition as benign congenital myopathy. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Myopathies.

For Medicare Advantage risk adjustment, G71.20 maps to CMS-HCC Category 197 (Muscular Dystrophy) under the V28 model, adding a risk factor of about 0.426 for a community, non-dual, aged beneficiary in payment year 2027.

Code Identity

ICD-10-CM Code
G71.20
Billable Status
Yes — Valid for Submission
Code Describes
Congenital myopathy, unspecified
Short Description
Congenital myopathy, unspecified
Same as the full description in the CMS dataset.
Parent Code
Congenital myopathies

Code Classification

ChapterG00–G99Diseases of the nervous system
SectionG70-G73Diseases of myoneural junction and muscle
CategoryG71Primary disorders of muscles
This CodeG71.20Congenital myopathy, unspecified

Medicare Risk Adjustment (HCC)Billing

G71.20 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2027.

CMS-HCC V28 Category (Payment Model)
HCC 197— Muscular Dystrophy
Payment HCC · PY 2027 one of 21 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+0.426
community, non-dual, aged · ranges 0.145–0.681 across segments
Hierarchy
Top of its hierarchy
HCC 197 is not superseded by any other condition category
Prior Model (CMS-HCC V24)
HCC 76
V24 retired V28 pays 100% of MA risk scores since PY 2026
Other CMS Models
PACE (CMS-HCC V22): HCC 76 · ESRD (V21): HCC 76 · ESRD (V24): HCC 76
ESRD V21 weights: 0.062 dialysis, 0.296–0.544 functioning graft · ESRD V24 weights: 0.136 dialysis, 0.322–0.842 functioning graft
Part D (RxHCC)
Not mapped
G71.20 does not risk-adjust in the RxHCC prescription drug model

Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Benign congenital myopathy
  • Congenital anomaly of skeletal muscle
  • Klippel-Feil anomaly, myopathy, facial dysmorphism syndrome
  • Klippel-Feil sequence
  • Minimal change myopathy

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to G71.20: its own notes plus those printed at G71.2, G71, and Chapter 6. A note printed at a category, block or chapter applies to every code under it.

Excludes2

Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.

From G71.2 Congenital myopathies applies to 5 codes
  • arthrogryposis multiplex congenita (Q74.3)
From G71 Primary disorders of muscles applies to 28 codes
  • arthrogryposis multiplex congenita (Q74.3)
  • metabolic disorders (E70-E88)
  • myositis (M60.-)
From Chapter 6 (G00-G99) Diseases of the nervous system applies to 700 codes
  • certain conditions originating in the perinatal period (P04-P96)
  • certain infectious and parasitic diseases (A00-B99)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Referenced in Other NotesGuidance

Instructional notes printed at other codes that name G71.20, its category, or a range that includes it.

Excludes2 1

These codes carry an Excludes2 note naming G71.20: its condition is not part of those codes, and both may be reported when the patient has both.

  • Block M60-M63 Disorders of muscles
    muscular dystrophies and myopathies (G71-G72) names G71-G72, which includes this code

Code First 1

These codes say to code first a condition named in the note, and G71.20 is one of the conditions named.

  • M62.84 Sarcopenia
    primary disorders of muscles (G71.-) names G71.-, which includes this code

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NVS018
Myopathies
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Myotonia Congenita

    inherited myotonic disorders with early childhood onset myotonia. muscular hypertrophy is common and myotonia may impair ambulation and other movements. it is classified as thomsen (autosomal dominant) or becker (autosomal recessive) generalized myotonia mainly based on the inheritance pattern. becker type is also clinically more severe. an autosomal dominant variant with milder symptoms and later onset is known as myotonia levior. mutations in the voltage-dependent skeletal muscle chloride channel are associated with the disorders.

Patient EducationClinical

Genetic Disorders

Genetic disorders are health conditions caused by changes (also called mutations or variants) in your genes. Genes are parts of DNA found in your cells that carry instructions for how your body grows, develops, and functions. Many genes tell your body how to make proteins, which are needed for your body to work properly.

The full article covers:

  • What are genetic disorders?
  • What causes genetic disorders?
  • What are the types of genetic disorders?
  • What are the different ways a genetic disorder can be inherited?
  • How are genetic disorders diagnosed?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Code History & ChangesHistory

Replacement G71.20 replaces the following previously assigned code(s):

  • G71.2 - Congenital myopathies
FY 2021AddedAdded to the ICD-10-CM code setEffective October 1, 2020.
FY 2022RevisedCode revised
FY 2023–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About G71.20Overview

What is the ICD-10 code for congenital myopathy, unspecified?

The ICD-10-CM code for congenital myopathy, unspecified is G71.20 (sometimes written as G7120). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

Is G71.20 (Congenital myopathies) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report congenital myopathy, unspecified on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What MS-DRG does G71.20 group to?

When congenital myopathy, unspecified is the principal diagnosis on an inpatient stay, it groups to MS-DRG 91, 92, 93, with relative weights from 0.7783 to 1.7050 depending on complications. Higher weights mean higher Medicare reimbursement.

Is G71.20 a CC or MCC?

CMS lists G71.20 as a CC (complication or comorbidity) for FY 2027. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 22 closely related codes in its exclusion list.

What HCC is G71.20?

G71.20 (congenital myopathy, unspecified) maps to CMS-HCC Category 197 (Muscular Dystrophy), commonly written as HCC 197, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2027. It mapped to HCC 76 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. It does not map to any RxHCC in the Part D prescription drug model.

Does G71.20 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, G71.20 adds a risk adjustment factor of about 0.426 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.145 to 0.681 depending on the payment segment). HCC 197 sits at the top of its hierarchy, so no other condition category supersedes it. See the full factor table on the HCC 197 category page.